Iloprost for the treatment of frostbite: a scoping review

• Published in: International Journal of Circumpolar Health
• Main Authors: Josianne Gauthier, Dunavan Morris-Janzen, Alexander Poole
• Format: Article in Journal/Newspaper
• Language: English
• Published: Taylor & Francis Group 2023
• Subjects: Iloprost; prostacyclin; vasodilator; frostbite; cold injury; amputation; Arctic medicine. Tropical medicine; RC955-962; Arctic; Circumpolar Health; International Journal of Circumpolar Health
• Online Access: https://doi.org/10.1080/22423982.2023.2189552; https://doaj.org/article/c8aa17b7f72b46f9ab2a7cd5fcdc6651

ABSTRACTWe performed a scoping review to identify the extent of the literature describing the use of iloprost in the treatment of frostbite. Iloprost is a stable synthetic analog of prostaglandin I2. As a potent inhibitor of platelet aggregation and vasodilator, it has been used to address the post-rewarming reperfusion injury in frostbite. The search using iloprost and frostbite as key words and MeSH terms yielded 200 articles. We included in our review the literature examining iloprost for the treatment of frostbite in humans in the form of primary research, conference proceedings and abstracts. Twenty studies published from 1994 to 2022 were selected for analysis. The majority were retrospective case series consisting of a homogeneous population of mountain sport enthusiasts. A total of 254 patients and over 1000 frostbitten digits were included among the 20 studies. The larger case series demonstrated a decrease in amputation rates relative to untreated patients. Primary gaps in the literature include a paucity of randomised trials and relatively limited study populations to date. While the case evidence is promising, a multi-centre collaboration would be crucial to adequately power prospective randomised studies to definitively determine if iloprost has a role in the treatment of frostbite.